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Purpose: The rapid death of many spinal motor neurons after nerve root avulsion injury results in 
limited functional recovery following replantation surgery of avulsed nerves into the spinal cord. 
Therefore, we investigated the neuroprotective effect of erythropoietin (EPO) on motor neurons after 
nerve root avulsion injury using a rat model. Methods: After C6 nerve root avulsion injury, EPO 
(2680 U/kg) was injected subcutaneously once a day for 3 consecutive days with various starting time 
points. At 28 and 56 days after injury, histological and immunohistological investigations were 
performed. Results: EPO-treated rats showed a significant increase in the number of surviving motor 
neurons at day 28 when the initial dose was started within 96 h after injury. In EPO-treated rats, 
superoxide formation in the motor neurons and proliferation of microglia were markedly suppressed 
in the acute phase. GAP-43-positive surviving motor neurons were significantly increased in 
EPO-treated rats at day 28. However, at 56 days after surgery, EPO-treated rats showed a much 
greater decrease of surviving motor neurons compared with those at day 28. Conclusion: The 
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Brachial plexus injury, especially nerve root avulsion injury, is one of the most difficult nerve 
injuries to treat. As root avulsion involves the disruption of the connection between the spinal cord 
and peripheral nerve, surgical repair has been considered impossible. Therefore, the current treatment 
option for nerve root avulsion injury includes nerve transfer, muscle graft or transfer, tendon transfer, 
or arthrodesis; however, functional recovery in the injured upper extremity is limited and insufficient 
(Atlan et al., 2012; Chuang, 2009; Doi et al., 1993). Replantation surgery of the avulsed nerve root 
into the spinal cord was reported in the 1990s. Although this surgery still has a number of unsolved 
shortcomings, limited functional recovery of the shoulder and elbow joints was seen in some cases 
(Carlstedt et al., 2000; Carlstedt et al., 2004). One of the important factors for obtaining good 
functional outcomes following this surgery appears to be the survival of motor neurons within the 
pertinent spinal cord segment (Carlstedt et al., 2000). After nerve root avulsion injury, the number of 
motor neurons in the affected spinal cord segment decreases rapidly and is reduced by more than half 
at 4 weeks (Wu, 1993; Yuan et al., 2009). Therefore, inhibition of motor neuron death may be a 
therapeutic strategy for nerve root avulsion injury (Havton et al., 2009). The hematopoietic hormone 
erythropoietin (EPO) shows neuroprotective effects in acute cerebral and spinal cord injuries (Matis et 
al., 2009; Sakanaka et al., 1998; Velly et al., 2010; Boran et al., 2005). The neuroprotective 
mechanisms of EPO include antagonizing the cytotoxic effect of glutamate, enhancing the expression 
of antioxidant enzymes, reducing nitric oxide-mediated formation of free radicals, and influencing 
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neurotransmitter release (Buemi et al., 2003). Although nerve root avulsion injury involves rupture of 
the ventral and dorsal roots, many motor neurons in the ventral horn of the spinal cord die within 4 
weeks after injury. The mechanisms of this motor neuron death are still unclear; however, nitric oxide 
and superoxide have been reported to contribute to motor neuron death (Estevez et al., 1998). We 
hypothesized that EPO has an inhibitory effect on motor neuron death after nerve root avulsion injury 
and investigated its effect using rat nerve root avulsion models.   
 
Materials and Methods  
 
Animals 
Eighty-four 9-week-old male adult Sprague–Dawley rats (Nippon SLC Inc., Hamamatsu, Japan) 
weighing approximately 280 g (270–300 g) were used. All animals were housed in a room with a 
daily 14-h light/10-h dark cycle with free access to food and water. Before surgery, rats were 
anesthetized intraperitoneally with sodium pentobarbital (40 mg/kg). All animal procedures were 
performed according to the Guidelines of the Animal Research Committee, Graduate School of 
Medicine, Kyoto University. 
 
Surgical procedure for C6 nerve root avulsion injury 
Surgery was performed as previously described (Noguchi et al., 2013). In brief, a midline skin 
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incision was made at the posterior side of the neck. The left paravertebral muscles of the cervical 
spine were unilaterally dissected from the spinous processes, laminae, and anterior articular processes 
(lateral mass) at the level of C4 to Th2. The transverse process and lateral third of the C5 and C6 
lateral mass were removed gently using a surgical bur. Then, the C6 nerve root was exposed and 
pulled gently using Adson forceps with no teeth. Successful nerve root avulsion was confirmed by 
visualization of the bifurcated stump of the avulsed nerve root and leakage of spinal fluid from the 
vertebral foramen.  
 
EPO injection 
Commercially available human recombinant EPO (Epoetin alpha) (Espo®; Kirin-Hakko, Tokyo, 
Japan) was used, and 2680 U/kg was subcutaneously injected into the lower back once a day for 3 
consecutive days as previously reported (Sekiguchi et al., 2003). The dose of rhEPO was established 
based on the bioavailability and clearance rates of rhEPO (Bleuel et al., 1996). 
 
Experiment 1: effect of EPO 28 days after injury 
Forty rats were randomly divided into the following eight groups according to the time of first EPO 
administration after surgery (n = 5 each): control (saline administration), immediate, 6 h, 24 h, 48 h, 





Experiment 2: effect of EPO 56 days after injury 
Twelve other rats were randomly divided into the following two groups (n = 6 each): control (saline 
administration) and EPO-treated (immediately after surgery). At 56 days after surgery, all rats were 
sacrificed for histological investigation.  
 
Tissue preparation 
The rats were deeply anesthetized with a lethal dose of sodium pentobarbital and transcardially 
perfused with 200 mL phosphate-buffered saline (PBS, pH 7.4) followed by 350 mL 4% (w/v) 
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH 7.4). Cervical spinal cord segments (5 
mm in length) were removed and post-fixed overnight in perfusion fixative at 4°C and cryoprotected 
for 24 h in 20% (w/v) sucrose in PB (4°C). Then, C6 spinal segments were cut in a cryostat into 
40-µm-thick serial transverse sections. The C6 spinal segment was defined as the area between the 
lower edge of the C5 dorsal rootlets and the upper edge of the C7 dorsal rootlets. 
 
Motor neuron counting 
For motor neuron counting, all sections were stained with 0.5% (w/v) cresyl violet (Nissl stain). The 
number of surviving motor neurons on the lesioned side of the spinal cord was counted in all sections 
and compared with the number on the unlesioned side according to our previous report (Noguchi et al., 
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2013). Large multipolar cells with abundant cytoplasm in the ventral horn were counted as viable 
motoneurons. To avoid double counting, the number of surviving motor neurons was corrected with 
Abercrombie’s formula (Clarke et al., 1995). The absence of cell loss was expressed as 100% of the 
contralateral control value. Cell counting for all serial sections was performed by two observers who 
were blinded to the groups. 
 
Experiment 3: detection of superoxide formation in injured motor neurons 
Superoxide formation in injured motor neurons was detected using hydroethidine (HEt; Invitrogen, 
Carlsbad, CA, USA) (Kim et al., 2010). HEt is oxidized to fluorescent ethidium by superoxide 
radicals and can therefore serve as a marker for superoxide production (Bindokas et al., 1996; 
Murakami et al., 1998). Six rats were randomly divided into the following two groups: EPO-treated 
group (2680 U/kg EPO was subcutaneously injected only once immediately after surgery; n = 3) and 
control group (1 mL saline was injected immediately after the surgery; n = 3). At 24 h after surgery, 
the rats were intravenously injected with 1 mL HEt (1 mg/mL) solution. After 2 h, the animals were 
deeply anesthetized with a lethal dose of sodium pentobarbital and then transcardially perfused with 
0.1 M PB at 4°C. Subsequently, the cervical spinal cord segments were removed and embedded in 
OCT compound followed by quick freezing in liquid nitrogen. Then, the central region of the C6 
spinal segments (500-µm length) was cut in a cryostat into 10-µm-thick serial transverse sections. The 
sections were fixed with 2% (w/v) PFA for 1 min, washed twice with PBS, and mounted in 50% (v/v) 
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glycerol. Fluorescent images were obtained using a fixed-power laser with a confocal laser 
fluorescent microscope (NICON EZ-C1, Tokyo, Japan). The number of oxidized-Het-positive cells 
was counted. Cell counting for all serial sections was performed by two observers who were blinded 
to the groups. Results were expressed as the mean number of oxidized-HEt-positive cells per section. 
 
Experiment 4: immunohistochemical analysis for growth associated protein 43 (GAP-43) and Iba-1 
Twenty rats were used and randomly divided into the following two groups (n = 10 each): control 
(saline) and EPO-treated (immediately after surgery). Ten rats were sacrificed on day 3 for 
immunostaining for Iba1 to detect activated microglia (control; n=5, EPO-treated; n=5). Another 10 
rats were sacrificed on day 28 for GAP-43 to detect the regenerative capacity of the injured motor 
neurons (control; n=5, EPO-treated; n=5) (Yuan et al., 2009). After transcardiac perfusion with PFA, 
removed C6 spinal segments were cut in a cryostat into 40-µm-thick serial transverse sections. The 
primary antibodies used for immunohistochemistry were rabbit polyclonal anti-Iba-1 (1:2000; Wako, 
Osaka, Japan) and rabbit polyclonal anti-GAP-43 (1:200; Chemicon, Temecula, CA, USA). Staining 
was performed according to the manufacturer’s protocol (Vector ABC Elite kit; Vector, Burlingame, 
CA, USA). The sections were pretreated with 0.3% (v/v) H2O2 in PBS and preincubated with 2% (v/v) 
normal goat serum in 0.2% (v/v) TritonX-100 in PBS at room temperature. Then, the sections were 
incubated overnight with the primary antibodies at 4°C. Secondary biotinylated anti-rabbit antibody 
(1:200; Vector) was applied for 1 h, followed by incubation with the avidin-biotin-peroxidase 
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complex reagent at room temperature for 30 min. The immunoreaction was visualized with 
diaminobenzidine, and sections were counterstained with an eight-fold dilution of Mayer’s 
hematoxylin solution (Wako, Osaka, Japan). The brown cells with nuclei in the lesioned ventral horn 
were considered immuno-positive. The number of immune-positive cells was counted using 
automated counting technique with Image J software (NIH, Bethesda, MD, USA). In brief, after the 
captured images were converted to grayscale images, the threshold was adjusted manually to separate 
the particles of interest from background. Then, the number of particles was counted. Cell counting 
for all serial sections was performed by two observers who were blinded to groups. Results were 
expressed as the mean number of immuno-positive cells per section.  
 
Experiment 5: erythropoietin receptor (EPOR) expression in avulsed motor neurons  
Six rats were used and randomly sacrificed on day 3, 7, and 14 after avulsion injury for EPOR (n=2 
at each time point). No injection was performed after injury. After transcardiac perfusion with PFA, 
removed C6 spinal segments were cut in a cryostat into 40-µm-thick serial transverse sections. The 
primary antibody used was rabbit polyclonal anti-EPOR (M-20; 1:200; Santa Cruz, CA, USA). 
Application of secondary antibody, visualization with diaminobenzidine, counterstaining, and cell 
counting were performed as mentioned above. Results were expressed as the mean number of 





All data were expressed as the mean ± standard error. The data from Experiment 1, 2, 4 (Iba-1), and 5 
were compared using one-way analysis of variance followed by Dunnett’s test or Tukey’s test, 
respectively (JMP 8, SAS Institute, Cary, NC, USA). The data from Experiment 3, and 4 (GAP-43) 
were compared using the unpaired t-test after normal distribution was confirmed. Statistical 
significance was set at p < 0.05. 
 
Results 
Experiment 1: effects of EPO 28 days after injury 
At 28 days after surgery, the number of surviving motor neurons on the lesioned side decreased in 
rats in both groups (Fig. 1). However, EPO-treated rats showed significantly more improvement of 
surviving motor neurons compared with control rats when the initial dose was started within 96 h after 
surgery (control: 47.9% ± 4.0, immediately: 74.2% ± 5.8, 6 h: 79% ± 3.3, 24 h: 77.6% ± 8.4, 48 h: 
75.5% ± 4.5, 96 h: 73.9% ± 7.6, 150 h: 53.1% ± 3.5, 300 h: 51.7% ± 0.8, p < 0.01) (Fig. 2). 
 
Experiment 2: effects of EPO 56 days after injury 
At 56 days after surgery, rats in each group showed a much greater decrease in the percentage of 
surviving motor neurons on the lesioned side compared with those 28 days after surgery (EPO treated: 
74.2% ± 5.8 at day 28, 45.6% ± 4.4 at day 56, control: 47.9% ± 4.0 at day 28, 31.8% ± 4.0 at day 56, 
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p < 0.01) (Fig. 3). The ratio of surviving motor neurons in rats in the EPO-treated group was 
significantly higher than that in rats in the control group (p < 0.01).  
 
Experiment 3: superoxide formation in injured motor neurons  
Superoxide in injured motor neurons oxidizes HEt to the red fluorescent dye ethidium. Thus, red 
motor neurons have an increased formation of intracellular superoxide. In EPO-treated rats, the 
number of oxidized-HEt-positive cells on the lesion side of the ventral horn significantly decreased 
compared with control rats 24 h after surgery (EPO treated: 1.7 ± 0.7, control: 12.3 ± 2.2, p < 0.05) 
(Fig .4). 
 
Experiment 4: immunohistochemical analysis for GAP-43 and Iba-1 
Microglial reaction in the lesioned ventral horn 
At day 3 after surgery, rats in both groups showed increased numbers of Iba-1-immunopositive cells 
on the lesioned side of the ventral horn compared with the unlesioned side of the ventral horn 
(unlesioned: 14.7 ± 2.0, EPO treated: 80.9 ± 8.9, control: 138.3 ± 12.1, p < 0.01) (Fig. 5D). However, 
the number of Iba-1-immunopositive cells was significantly lower in EPO-treated rats compared with 
control rats (p < 0.01). Almost all microglia in the unlesioned side showed a ramified form (inset of 
Fig. 5A). In contrast, many microglia on the lesioned side showed a morphological change to an 




The regenerative capacity of injured motor neurons 
At day 28 after surgery, the number of GAP-43-immunopositive cells on the lesioned side of the 
ventral horn was significantly higher in EPO-treated rats compared with control rats (EPO: 3.8 ± 0.6, 
control: 0.8 ± 0.2, p < 0.01). The percentage of surviving motor neurons immuno-positive for GAP-43 
on the lesioned side was 75.7 ± 3.7 % in EPO-treated rats and 29.1 ± 9.8% in control rats (p < 0.01) 
(Fig. 6).  
 
Experiment 5: EPOR expression in avulsed motor neurons 
EPOR expression was observed in the cell bodies of all motor neurons on both sides of the ventral 
horn. No significant difference was found in EPOR expression in motor neurons on the lesioned side 
among the assessed time points (unlesioned side: 9.6 ± 0.5, day 3: 9.5 ± 0.5, day 7: 8.9 ± 0.5, day 14: 
7.9 ± 0.5) (Fig. 7).  
 
Discussion 
The present study showed that 1) subcutaneous injection of EPO once a day for 3 days significantly 
increased the number of surviving motor neurons 28 days after nerve root avulsion injury even when 
the first administration was delayed until 96 h after injury,  2) in EPO-treated rats, superoxide 
formation in the motor neurons and proliferation of microglia were markedly suppressed in the acute 
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phase, 3) GAP-43-positive surviving motor neurons were significantly increased in EPO-treated rats 
at day 28, and 4) at 56 days after injury, a much greater decrease in the percentage of surviving motor 
neurons on the lesioned side compared with those 28 days after surgery. However, EPO-treated rats 
still showed a significant increase in surviving motor neurons compared with control rats. 
Traumatic injury to the central nervous system results in immediate mechanical damage followed by 
prolonged secondary injury to neural tissues (Tator et al., 1991). Unlike spinal cord contusion injury, 
the primary mechanical damage caused by nerve root avulsion is usually minor in the spinal cord 
(Noguchi et al., 2013). However, many motor neurons in the ventral horn die within 4 weeks after 
nerve root avulsion injury. A variety of cytotoxic mechanisms evolving from primary mechanical 
damage are induced, such as so-called secondary spinal cord injury, which progresses irreversibly 
(Borgens et al., 2012). This delayed injury mechanism is one of the targets for therapeutic intervention 
to improve treatment for nerve root avulsion injury. 
In our study, the subcutaneous injection of EPO significantly increased the number of surviving 
motor neurons 4 weeks after injury. After axonal injury, neuron-derived nitric oxide stimulates EPO 
production by neighboring Schwann cells (Keswani et al., 2004). Then, this Schwann cell-derived 
EPO results in activation of an “axonoprotective” pathway via EPOR ligation on neurons. After root 
avulsion injury, endogenous EPO produced by Schwann cells in the remaining short ventral rootlets is 
exhausted shortly after injury. Therefore, systemic administration of EPO may counteract the 
insufficient production of endogenous EPO.  
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In our previous rat study, although the ventral roots were disconnected within the subarachnoid space 
in both an intradural rhizotomy group and a nerve root avulsion group, the root avulsion group 
showed a significant decrease in motor neurons compared with the rhizotomy group (Noguchi et al., 
2013). Only the root avulsion group showed intraspinal bleeding along motor neuron axons 12 h after 
injury. Therefore, we inferred that the traction force to the nerve root causes severe injury to motor 
neurons and their axons and affects the difference in motor neuron survival between the two groups. 
However, motor neuron death after root avulsion injury is likely caused by not only the mechanical 
insult but also other neurotoxic mechanisms (Carlstedt, 2008). The intraspinal bleeding along motor 
neuron axons after nerve root avulsion injury includes iron, which is an important initiator of free 
radical oxidation (Halliwell, 1992). Free radicals are neurotoxic substances in the central nervous 
system. In the present study, EPO-treated rats showed a marked decrease in HEt staining compared 
with control rats 24 h after injury. One of the neuroprotective mechanisms of EPO after nerve root 
avulsion injury is likely suppression of free radical formation. 
In the normal central nervous system, ramified resting microglia constantly monitor the surrounding 
microenvironment (Nimmerjahn et al., 2005). Injury to nervous tissue induces activation of resting 
microglia via various “danger signals” from neighboring damaged neuronal cells (Loane et al., 2010). 
Then, depending on the degree of activation, microglia release neurotrophic and anti-inflammatory 
factors for neuron survival or neurotoxic factors such as superoxide, nitric oxide, and tumor necrosis 
factor-α (Block et al., 2007). In the present study, EPO-treated rats showed a significant decrease in 
 15 
 
activated microglia at 3 days after nerve root avulsion injury. The suppression of intraneuronal free 
radical formation by EPO release less “danger signals” from neurons and results in an indirect 
inhibitory effect on microglial activation. Moreover, with the antioxidant action of EPO, the 
microenvironment produced by already activated microglia may be modulated to a less favorable one 
for the development of free radicals (Wenker et al., 2013).  
After spinal contusion injury, administration of free radical scavengers as early as possible shows a 
neuroprotective effect by inhibiting the secondary spinal cord injury process (Ohta et al., 2011). 
However, our study showed that EPO significantly improved motor neuron survival even when the 
first administration was delayed until 4 days after nerve root avulsion injury. Compared with spinal 
cord contusion injury, parenchymal mechanical damage is minor in nerve root avulsion injury 
(Noguchi et al., 2013). Therefore, nerve root avulsion causes less neurotoxic events induced by free 
radical formation compared with spinal cord contusion injury. Thus, the window of opportunity for 
administration of EPO after nerve root avulsion injury is longer than that after spinal contusion injury.  
Although EPORs were detected in motor neurons on the lesioned side of the ventral horn, 
administration of EPO did not provide a neuroprotective effect when the initial dose was started 1 or 2 
weeks after injury. This may be because an irreversible cascade of neuronal cell death may have 
already started. 
The up-regulation of GAP-43 in motor neurons after root avulsion injury has been reported to 
correlate with motor neuronal regeneration (Yuan et al., 2009). Yuan et al. showed that GAP-43 was 
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expressed within 2 weeks after injury and returned to minimal levels at 4 weeks. Therefore, the 
preferred timing of replantation surgery was suggested to be within 2 weeks after injury. In the present 
study, the administration of EPO induced a significant increase in the number of GAP-43 
immuno-positive surviving motor neurons at 4 weeks after injury. EPO also prolonged the 
regeneration capacity of avulsed motor neurons. 
Delayed replantation surgery was reported to show a significant decrease in not only survival, but 
also regeneration of avulsed spinal motor neurons compared with replantation surgery immediately 
after injury. If replantation surgery of the avulsed nerve roots is performed as early as possible, better 
functional recovery would be expected. However, in clinical cases, the diagnosis and treatment for 
brachial plexus avulsion injuries are usually delayed for various reasons such as coexisting 
life-threatening injuries. Even if a patient is able to consult a specialist early after injury, at least 
several weeks may be required to receive a detailed diagnosis and subsequent surgery. If medication 
becomes available that will prevent neuronal loss and prolong the regeneration capacity of motor 
neurons after avulsion injury, the time before replantation surgery can be extended. 
In the present study, the dosage of EPO was determined according to bioavailability and clearance 
rates (Sekiguchi et al., 2003). EPO exerts a neuroprotective effect at a higher dose compared with the 
erythropoietic dose. Therefore, when using EPO as a neuroprotective agent, undesirable 
erythrocytosis and a prothrombotic state may result. However, this may not be a substantial problem 
for short-term administration of EPO (Kwon et al., 2005). The present study showed a marked 
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decrease in preserved motor neurons 56 days after surgery in EPO-treated rats compared with 28 days 
after surgery. This limited neuroprotective effect on motor neurons was provided by 3 days of EPO 
administration. Although a longer period of EPO administration may provide a greater 
neuroprotective effect, this shorter administration time would be sufficient to increase the time before 
replantation surgery can be performed.  
 
Conclusion 
The present study indicates that EPO has a neuroprotective effect on spinal motor neurons after 
nerve root avulsion injury. EPO-treated rats showed a significant increase in the number of surviving 
motor neurons at day 28 when the initial dose was started within 96 h after injury. The neuroprotective 
effect of EPO after root avulsion injury did not last long, but would be sufficient to increase the time 
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Figure 1.  
Representative images of the C6 ventral horn 28 days after surgery. A: unlesioned side. B: lesioned 
side in EPO-treated rats (first administration was 24 h after injury). C: lesioned side in control rats. 
More surviving motor neurons were seen in EPO-treated rats compared with control rats (Nissl 
staining, Bar: 100 µm). 
 
Figure 2.  
The relationship between timing of the initial administration of EPO after surgery for 3 days and the 
number of surviving motor neurons (n = 5 each). Starting EPO administration within 96 h of surgery 
produced a significant increase in the number of surviving motor neurons 28 days after injury (*p < 
0.01). All data are the mean ± SE. 
 
Figure 3.  
Time course of the number of surviving motor neurons after injury (n = 6 each). The number of 
surviving motor neurons in both groups decreased with time. Compared with control rats, the 
EPO-treated rats demonstrated a significantly higher ratio of surviving motor neurons at 28 and 56 





Detection of superoxide formation using hydroethidine (HEt) in motor neurons in the lesioned ventral 
horn 24 h after surgery. A: unlesioned side in control rats. B: lesioned side in EPO-treated rats (only 
once immediately after surgery. n = 3). C: lesioned side in control rats (n = 3). D: In EPO-treated rats, 
the number of oxidized-HEt-positive cells on the lesioned side of the ventral horn was significantly 
decreased compared with those in control rats 24 h after surgery (*p < 0.05) (Bar: 50 µm).  
 
Figure 5.  
Immunohistochemistry for Iba-1 3 days after surgery (control; n = 5, EPO-treated; n = 5). A: 
unlesioned side in control rats. B: lesioned side in EPO-treated rats. C: lesioned side in control rats. 
Almost all microglia in the unlesioned side showed a ramified form (inset of A). In contrast, many 
microglia on the lesioned side showed a morphological change to an amoeboid form (inset of B and 
C). Iba-1-immunopositive cells were significantly increased in the ventral horn on the lesioned side 
compared with the unlesioned side (* p < 0.01) (D). Iba-1-immunopositive cells were significantly 
reduced in EPO-treated rats compared with control rats (** p < 0.01) (Bar: 100 µm). 
 
Figure 6.  
Immunohistochemistry for GAP-43 28 days after surgery (control; n = 5, EPO-treated; n = 5). A: a 
representative image of the lesioned C6 ventral horn in EPO-treated rats (A) and control rats (B) (Bar: 
 24 
 
100µm). Black Arrows indicate surviving motor neurons immuno-positive for GAP-43 and white 
arrows indicate surviving motor neurons immuno-negative for GAP-43. The representative enlarged 
image of surviving motor neurons immune-positive and immune-negative for GAP-43 (C) (Bar: 
50µm). The ratio of GAP-43-immunopositive cells was significantly increased in EPO-treated rats 
compared with control rats (*p < 0.01) (D). 
 
Figure 7.  
Immunohistochemistry for EPOR at 3, 7, and 14 days after surgery (n = 2 each). Representative 
images of the unlesioned C6 ventral horn on day 3 (A), lesioned side on day 3 (B), lesioned side on 
day 7 (C), and lesioned side on day 14 (D) (Bar: 100 µm). No significant difference was found in 
EPOR expression in motor neurons among the lesioned side at 3, 7, and 14 days after surgery (E). 
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